Hints and tips:
Related Special Reports
...“There’s been growing demand for V-neck sweaters, with searches for the style increasing by 10 per cent this year versus 2023,” says Daniel Todd, buying director of Mr Porter, where sales of the style have...
...Daniel Loeb’s Third Point gained nearly $400m in a bullish bet on the outcome of the US election, positioning the billionaire as one of the hedge fund winners from recent market gyrations....
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...Additional reporting by Guy Chazan in Berlin, Joe Miller in Frankfurt and Daniel Dombey in Madrid...
...The vaccination campaign started after the EU’s medicine regulator approved the BioNTech/Pfizer vaccine, the first Covid-19 shot to get the green light, on Monday....
...“Together with Pfizer, we are also working with various organisations to support the supply of vaccines to populations worldwide....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...A version of this article was first published by Nikkei Asia on October 19 2021. ©2021 Nikkei Inc. All rights reserved....
...Additional reporting by Guy Chazan in Berlin, Daniel Dombey in Madrid and Leila Abboud in Paris...
...‘Perfect scenario’ Those look like V-shaped projections, Andrew Glenn thought to himself....
...“This is not going to be a V-shaped recovery from here given the many months [or] years it will take for full repair, but it feels good now.”...
...But all that will have to wait for now, perhaps until next year as a coronavirus vaccine breakthrough by Pfizer and Germany’s BioNTech offers a glimmer of hope just in time for the holidays....
...“She prefers to storm ahead, without consulting anyone, and do everything herself,” wrote Ulrike Demmer and Daniel Goffart in a von der Leyen biography that was published in 2015....
...“Markets are pricing a V [shaped recovery], everyone’s coming back to work, and this is going to be fine,” Mr Falco said. “I don’t think it’s going to be that easy quite frankly.”...
...Early last year Bristol-Myers Squibb purchased Celgene for $93bn, while Pfizer snapped up Array BioPharma for $11bn in June....
...(FT) News round-up Pfizer to boost cancer treatment portfolio with $11.4bn Array deal (FT) Nissan expands internal investigation into Carlos Ghosn (FT) Deutsche Bank to set up €50bn ‘bad bank’ as part...
...Idexx said in October that the animal health market had experienced a “V-shaped recovery”....
...A decade ago, Jeffrey Kindler, then chief executive of US drugs giant Pfizer, was plotting an audacious $68bn acquisition of rival Wyeth....
...China is Pfizer’s third biggest market after the US and Japan....
...These included acquisitions such as Ewos, a Norwegian salmon feed company, and Diamond V, a manufacturer of yeast culture products to aid animal health....
...GBH’s price target would imply a market cap of about $217.35bn for Netflix — compared with $173.5bn at present — and would put it just ahead of where Pfizer, Mastercard, Cisco and Boeing are sitting today...
...The sale of the 36.5 per cent share is part of a realignment taking place in the global consumer healthcare sector, which has also seen Pfizer of the US put its consumer healthcare unit up for sale....
...“It’s new households coming into the middle class stage which is driving consumption,” says Daniel Zipser of consultancy McKinsey. “The auto industry very much depends on China....
International Edition